Bringing promising ADC candidates to market faster hinges on the biopharma industry investing in linker design capabilities.
Pamela James
Advertisement
Pamela James, PhD, is vice-president, Product, Vector Laboratories.
Articles by Pamela James
Glycosylation analysis can provide a deep and nuanced understanding of immune cell phenotype and function.
Advertisement
Latest Updated Articles
Valuing Specialized Experience in ADC DevelopmentPublished: September 25th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
